Streetbeat News

Products Services

DGX

Quest Diagnostics has announced a collaboration aimed at accelerating the adoption of digital and AI pathology innovations to enhance the quality, speed, and efficiency of diagnosing cancer and other diseases.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:58 am

PFE

Pfizer plans to sell its Covid and migraine drugs directly to consumers, as reported by the Financial Times. This move could potentially reshape the pharmaceutical distribution landscape and impact how consumers access these medications.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:45 am

NXU

Nxu has expanded its EV charging subscription service, now offering cutting-edge EV charging and energy storage solutions to cater to the growing demand for electric vehicle infrastructure.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:36 am

TFX

Teleflex announced that multiple clinical and real-world evidence studies will be presented at the 2024 American Urological Association Annual Meeting, showcasing the company's contributions to urological care.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:35 am

BAM

BEP

MSFT

Brookfield Asset Management, Brookfield Renewable, and Microsoft have signed a global renewable energy framework agreement. This partnership aims to support Microsoft's objective of sourcing 100% of its electricity consumption from renewable energy sources. The collaboration underscores the commitment of all parties to sustainability and renewable energy initiatives.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:34 am

GTHX

G1 Therapeutics reaffirmed its 2024 net COSELA revenue guidance of $60M-$70M, expecting its cash runway to extend into Q3 of 2025. This outlook is based on anticipated acceleration of COSELA sales in the U.S.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:33 am

GTHX

G1 Therapeutics and Pepper Bio have entered into a global licensing agreement for Lerociclib, covering all uses except certain radioprotectant applications, excluding the Asia-Pacific region. This partnership could enhance the commercial potential of Lerociclib, potentially impacting G1 Therapeutics' market position and financial outlook.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:26 am

TSLA

XPEV

XPeng Inc. (NYSE:XPEV) reported a 33% year-on-year increase in vehicle deliveries for April, totaling 9,393 units, and a 4% increase over the previous month. The company highlighted the success of its XNGP ADAS and the X9 model, which is the top-selling all-electric MPV in China. Year-to-date, XPENG has delivered 31,214 Smart EVs, marking a 23% increase from the previous year. XPENG also introduced the AI Valet Driver feature and announced its new brand, MONA, set to launch in June 2024. Despite these announcements, XPEV shares are trading slightly lower at $8.12 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

May 01, 2024 | 10:25 am

AUPH

Aurinia Pharmaceuticals has launched initiatives to enhance awareness about Lupus Nephritis, emphasizing the importance of regular screening and effective management.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:19 am

BYON

Beyond (BYON) has announced a partnership with Extend to offer customers modern shipping and product protection solutions. This collaboration aims to enhance customer satisfaction and loyalty by providing comprehensive protection for purchases.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:18 am